For patients with overweight or obesity and T2D, dapagliflozin plus regular calorie restriction is associated with a significantly higher rate of remission of diabetes compared with calorie ...

Findings indicate that dapagliflozin and calorie restriction together improve weight loss and metabolic health, increasing ...

The combined regimen achieved a higher remission rate than calorie restriction alone in people with overweight or obesity and ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

China: Combining dapagliflozin with calorie restriction resulted in a higher rate of type 2 diabetes (T2D) remission, along ...

The results of this cohort study suggest that individuals with type 2 diabetes who initiated treatment with empagliflozin or dapagliflozin had comparable long-term kidney outcomes. These ...

Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes. (HealthDay News) — For patients with overweight or obesity and type 2 diabetes ...

Diabetes remission was achieved in 44 and 28% of patients in the dapagliflozin and placebo groups, respectively. HealthDay News — For patients with overweight or obesity and type 2 diabetes ...

No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.

Dapagliflozin alongside moderate calorie restricted diet leads to much higher rates of remission from early type 2 diabetes, a study found.